Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Zoetis Inc.
Report date May 20, 2021 · Filed May 24, 2021
Section 16 reporting ended · disclosed 2021-05-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 215,129 |
Reported balance
After 2021-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-05-20 · Exercise / conversion · Acquired 130 · Balance 215,129 F1: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 29,086.0632 |
Reported balance
After 2021-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-20 · Exercise / conversion · Disposed 130.8769 · Balance 29,086.0632 F2: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F3: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F4: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F5: Not applicable. F6: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022; and 1,302.2257 RSUs will vest on February 10, 2024. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 27,783.8375 |
Reported balance
After 2021-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-05-20 · Disposition to issuer · Disposed 1,302.2257 · Balance 27,783.8375 F2: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F3: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F4: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F5: Not applicable. F7: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.
F2: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F3: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
F4: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F5: Not applicable.
F6: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022; and 1,302.2257 RSUs will vest on February 10, 2024.
F7: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2021 Filed May 24, 2021 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Disposition to issuerRestricted Stock Unit · Derivative | 1,302.2257 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,783.8375 Underlying: Common Stock · 1,302.2257 shares Expires not disclosed F2 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F4 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F5 · derivative.expiration_date: Not applicable. F7 · balance_after: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 130.8769 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · derivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,086.0632 Underlying: Common Stock · 130.8769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F4 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F5 · derivative.expiration_date: Not applicable. F6 · balance_after: The RSUs vest as follows: 27,783.8375 RSUs will vest on February 12, 2022; and 1,302.2257 RSUs will vest on February 10, 2024. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 130 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000239 · wf-form4_162189130879346.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs) in connection with Mr. Alaix's retirement from the Zoetis Board of Directors. Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 21:03 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 1,780.899 | $49.51 | $88,172.31 |
DisclosureSEC source: 0001555280-21-000162 · wf-form4_161722460716646.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,864.5315 Underlying: Common Stock · 556.6785 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 133,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · derivative · entry 5 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,192 Underlying: Common Stock · 133,070 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 3,000 | $161.76 | $485,280.00 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,307 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.68 to $161.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 63,029 | $160.89 | $10,140,735.81 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,307 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.48 to $161.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 67,041 | $160.17 | $10,737,956.97 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,336 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.48 to $160.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 133,070 | $73.24 | $9,746,046.80 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:38 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 54,784.8004 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000130 · wf-form4_161360152135046.xml · derivative · entry 6 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,784.8004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:38 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionRestricted Stock Unit · Derivative | 37,528.6472 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000130 · wf-form4_161360152135046.xml · derivative · entry 5 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,174.0748 Underlying: Common Stock · 37,528.6472 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 37,528.6472 RSUs vested on February 13, 2021; 27,743.0748 RSUs will vest on February 12, 2022; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 37,528.6472 RSUs vested on February 13, 2021; 27,743.0748 RSUs will vest on February 12, 2022; and 1,431 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 37,528.6472 RSUs vested on February 13, 2021; 27,743.0748 RSUs will vest on February 12, 2022; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:38 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 29,310 | $166.71 | $4,886,270.10 |
DisclosureSEC source: 0001555280-21-000130 · wf-form4_161360152135046.xml · nonDerivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,307 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:38 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 54,784 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000130 · wf-form4_161360152135046.xml · nonDerivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:38 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 19,920 | $166.71 | $3,320,863.20 |
DisclosureSEC source: 0001555280-21-000130 · wf-form4_161360152135046.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,833 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:38 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 37,528 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000130 · wf-form4_161360152135046.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:46 UTC | Zoetis Inc. ZTS · Entity 679 | GrantRestricted Stock Unit · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000070 · wf-form4_161316998998299.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,702.722 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 37,528.6472 RSUs will vest on February 13, 2021; 27,743.0748 RSUs will vest on February 12, 2022; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:57 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPerformance Award Unit · Derivative | 54,784.8004 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000026 · wf-form4_161308420398943.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,784.8004 Underlying: Common Stock · 54,784.8004 shares Expires not disclosed F1 · security: Represents performance award units with a three-year performance period covering 2018-2020 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 13, 2021, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 14, 2021 Filed Jan 20, 2021 00:02 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionDeferred Stock Unit · Derivative | 353,943.4235 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000002 · wf-form4_161110095977136.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 353,943.4235 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F4 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F1 · price: Acquisition of common stock upon settlement of deferred stock units (DSUs) pursuant to the Zoetis Equity Deferral Plan. Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F3 · derivative.exercise_date: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F3 · derivative.expiration_date: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| January 14, 2021 Filed Jan 20, 2021 00:02 UTC | Zoetis Inc. ZTS · Entity 679 | Tax withholdingCommon Stock | 186,981 | $160.96 | $30,096,461.76 |
DisclosureSEC source: 0001555280-21-000002 · wf-form4_161110095977136.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,225 Read SEC document |
| January 14, 2021 Filed Jan 20, 2021 00:02 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 353,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000002 · wf-form4_161110095977136.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon settlement of deferred stock units (DSUs) pursuant to the Zoetis Equity Deferral Plan. Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F2 · shares: Represents the actual number of whole shares delivered to the reporting person upon settlement of the DSUs. For each award of DSUs, any amount of fractional DSUs is rounded down to zero. F1 · price: Acquisition of common stock upon settlement of deferred stock units (DSUs) pursuant to the Zoetis Equity Deferral Plan. Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 21:30 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 22,428 | $165.99 | $3,722,823.72 |
DisclosureSEC source: 0001555280-20-000318 · wf-form4_160564861834659.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,266 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.59 to $166.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 21:30 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 69,319 | $165.29 | $11,457,737.51 |
DisclosureSEC source: 0001555280-20-000318 · wf-form4_160564861834659.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,694 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.59 to $165.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:38 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 61.1716 | $45.27 | $2,769.24 |
DisclosureSEC source: 0001555280-20-000239 · wf-form4_159536389884395.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,083.6325 Underlying: Common Stock · 19.1431 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 21:09 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 2,393.9422 | $38.93 | $93,196.17 |
DisclosureSEC source: 0001555280-20-000183 · wf-form4_158715776439399.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,022.4609 Underlying: Common Stock · 752.7354 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 23:11 UTC | Zoetis Inc. ZTS · Entity 679 | GrantPhantom Stock Unit · Derivative | 4,353.2509 | $37.07 | $161,375.01 |
DisclosureSEC source: 0001555280-20-000160 · wf-form4_158586906620664.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,628.5187 Underlying: Common Stock · 1,371.1871 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 170,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · derivative · entry 12 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,262 Underlying: Common Stock · 170,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F13 · derivative.exercise_price: 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F14 · balance_after: 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 48,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · derivative · entry 11 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,425 Underlying: Common Stock · 48,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F11 · derivative.exercise_price: 48,045 options granted February 19, 2016 at an exercise price of $41.83 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F12 · balance_after: 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 7,499 | $143.13 | $1,073,331.87 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 9 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F5 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.03 to $143.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 48,487 | $142.40 | $6,904,548.80 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 8 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,512 F4 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.02 to $143.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 78,738 | $141.33 | $11,128,041.54 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 7 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,999 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.01 to $142.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 83,484 | $140.68 | $11,744,529.12 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 6 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,737 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $141.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 170,163 | $55.02 | $9,362,368.26 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 5 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 48,045 | $41.83 | $2,009,722.35 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 45,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · derivative · entry 10 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,470 Underlying: Common Stock · 45,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 45,452 options granted February 19, 2016 at an exercise price of $41.83 per option. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F10 · balance_after: 48,045 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 13,930 | $141.21 | $1,967,055.30 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.01 to $141.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 31,522 | $140.41 | $4,426,004.02 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,943 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $141.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 21:26 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 45,452 | $41.83 | $1,901,257.16 |
DisclosureSEC source: 0001555280-20-000140 · wf-form4_158344355335410.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:14 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 120,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000134 · wf-form4_158257884237367.xml · derivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,922 Underlying: Common Stock · 120,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 26,183 options granted February 27, 2015 at an exercise price of $46.09 per option and 94,170 options granted February 19, 2016 at an exercise price of $41.83 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 93,497 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:14 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 120,353 | $142.32 | $17,128,638.96 |
DisclosureSEC source: 0001555280-20-000134 · wf-form4_158257884237367.xml · nonDerivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:14 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 94,170 | $41.83 | $3,939,131.10 |
DisclosureSEC source: 0001555280-20-000134 · wf-form4_158257884237367.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:14 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 26,183 | $46.09 | $1,206,774.47 |
DisclosureSEC source: 0001555280-20-000134 · wf-form4_158257884237367.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 20,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000132 · wf-form4_158232010399117.xml · derivative · entry 7 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 627,275 Underlying: Common Stock · 20,725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F8 · derivative.exercise_price: 20,725 options granted February 27, 2015 at an exercise price of $46.09 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F9 · balance_after: 26,183 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 20,725 | $143.61 | $2,976,317.25 |
DisclosureSEC source: 0001555280-20-000132 · wf-form4_158232010399117.xml · nonDerivative · entry 5 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.50 to $144.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 20,725 | $46.09 | $955,215.25 |
DisclosureSEC source: 0001555280-20-000132 · wf-form4_158232010399117.xml · nonDerivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionStock Option · Derivative | 63,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000132 · wf-form4_158232010399117.xml · derivative · entry 6 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648,000 Underlying: Common Stock · 63,046 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 63,046 options granted February 27, 2015 at an exercise price of $46.09 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 46,908 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 100 | $144.65 | $14,465.00 |
DisclosureSEC source: 0001555280-20-000132 · wf-form4_158232010399117.xml · nonDerivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | SaleCommon Stock | 62,946 | $144.03 | $9,066,112.38 |
DisclosureSEC source: 0001555280-20-000132 · wf-form4_158232010399117.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,113 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.59 to $144.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:22 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionCommon Stock | 63,046 | $46.09 | $2,905,790.14 |
DisclosureSEC source: 0001555280-20-000132 · wf-form4_158232010399117.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:18 UTC | Zoetis Inc. ZTS · Entity 679 | GrantDeferred Stock Unit · Derivative | 66,772.2058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-20-000115 · wf-form4_158215071065836.xml · derivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,477.4275 Underlying: Common Stock · 66,772.2058 shares Expires not disclosed F4 · security: Represents DSUs received pursuant to the Zoetis Equity Deferral Plan. DSUs are fully vested and are settled, together with dividend equivalent units automatically issued thereon, in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F5 · derivative.exercise_price: Each DSU represents the right to receive one share of Zoetis Inc. common stock in accordance with the terms of the Zoetis Equity Deferral Plan. F7 · price: Upon the vesting of the reporting person's performance award units on 2/14/2020, the reporting person received 66,772.2058 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.exercise_date: Upon the vesting of the reporting person's performance award units on 2/14/2020, the reporting person received 66,772.2058 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.expiration_date: Upon the vesting of the reporting person's performance award units on 2/14/2020, the reporting person received 66,772.2058 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 22:18 UTC | Zoetis Inc. ZTS · Entity 679 | Exercise / conversionPerformance Award Unit · Derivative | 66,772.2058 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-20-000115 · wf-form4_158215071065836.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,772.2058 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Vesting of performance award units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F7 · derivative.exercise_date: Upon the vesting of the reporting person's performance award units on 2/14/2020, the reporting person received 66,772.2058 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. F7 · derivative.expiration_date: Upon the vesting of the reporting person's performance award units on 2/14/2020, the reporting person received 66,772.2058 DSUs pursuant to a voluntary deferral under the Zoetis Equity Deferral Plan. The DSUs are fully vested and will be settled in shares of Zoetis common stock in the January following the reporting person's termination of employment from Zoetis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.